Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer

相似書籍

• Effects of Pharmacokinetic Processes and Varied Dosing Schedules on the Dynamics of Acquired Resistance to Erlotinib in EGFR-Mutant Lung Cancer
  由: Foo, Jasmine, et al.
  出版: (2012)
• Optimization of Dosing for EGFR-Mutant Non–Small Cell Lung Cancer with Evolutionary Cancer Modeling
  由: Chmielecki, Juliann, et al.
  出版: (2011)
• Induction of BIM Is Essential for Apoptosis Triggered by EGFR Kinase Inhibitors in Mutant EGFR-Dependent Lung Adenocarcinomas
  由: Gong, Yixuan, et al.
  出版: (2007)
• Clinical impact of subclonal EGFR T790M mutations in advanced-stage EGFR-mutant non-small-cell lung cancers
  由: Vaclova, Tereza, et al.
  出版: (2021)
• Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR mutant lung cancer: Distinct natural history of patients with tumors harboring the T790M mutation
  由: Oxnard, Geoffrey R., et al.
  出版: (2010)